- Press Releases
- Explore Topics
- People and Events
Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
A drug developed by InterPharm Laboratories Ltd. was first isolated and cloned by Prof. Michel Revel.
Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the...
Prof. Haim Aviv is starting his sixth bio-tech company
Clinical trials of the multiple sclerosis drug, Rebif, are proving its effectiveness